Thomsen LM. Patient safety in relation to biosimilars – how can we act as a patient organisation? EULAR 2017, OP0328-PARE.
MUC5B-promotervariant rs35705950 risicofactor voor RA-geassocieerde ILD
jan 2019 | ILD, RA
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE